✦ LIBER ✦

Inhibitors of α-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson’s disease and related disorders

✍ Scribed by Dena A. M. Amer; G. Brent Irvine; Omar M. A. El-Agnaf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O2-06-03 A strategy for designing inhibi

✍ Omar M. El-Agnaf; Katerina E. Paleologou; David Allsop 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Phosphorylated α-synuclein as a potentia

✍ Foulds, Penelope; Mann, David MA; Allsop, David 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 270 KB

α-Synuclein is a pathological link and t

✍ Shahaduzzaman, Md; Acosta, Sandra; Bickford, Paula C.; Borlongan, Cesar V. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 736 KB

[Journal of Neural Transmission. Supplem

✍ Riederer, P.; Reichmann, H.; Youdim, M. B. H.; Gerlach, M. 📂 Article 📅 2006 🏛 Springer Vienna ⚖ 76 KB

[Journal of Neural Transmission. Supplem

✍ Riederer, P.; Reichmann, H.; Youdim, M. B. H.; Gerlach, M. 📂 Article 📅 2006 🏛 Springer Vienna ⚖ 370 KB

17β- and 17α-estradiol are non-competiti

✍ James A. Dykens; Christophe Wersinger; Anita Sidhu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB